Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01326117
Recruitment Status : Withdrawn (lack of patients who meet inclusion criteria; there was one screen failure)
First Posted : March 30, 2011
Last Update Posted : July 29, 2014
Duke University
Eli Lilly and Company
Information provided by (Responsible Party):
Mark Feinglos, Duke University Medical Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : December 2013
  Study Completion Date : December 2013